Walter del Pinal
Medical · Los Angeles, CANPI 1356451082
Payments from drug & device makers
Across 221 payments — averaging $23.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$806
- Boehringer Ingelheim$541
- Novo Nordisk$475
- Lilly USA, LLC$417
- Bayer$276
- plus $1K from 17 others
What the payments were for
- Food & beverage$5,172100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 51 | $1,403 |
| AstraZeneca | 39 | $806 |
| Boehringer Ingelheim | 21 | $541 |
| Novo Nordisk | 24 | $475 |
| Lilly USA, LLC | 23 | $417 |
| Bayer | 7 | $276 |
| Pfizer | 9 | $233 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $128 |
| GSK | 6 | $120 |
| Xeris Pharmaceuticals, Inc. | 5 | $112 |
| Amgen | 4 | $109 |
| Aimmune Therapeutics, Inc. | 4 | $107 |
| Phathom Pharmaceuticals, Inc. | 4 | $98 |
| Exact Sciences | 4 | $85 |
| Sanofi-aventis U.S. LLC | 3 | $67 |
| Eisai Inc. | 3 | $48 |
| Novartis | 2 | $42 |
| Ironwood Pharmaceuticals, Inc | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $24 |
| Merck | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,184 in reported general payments places this provider in the 85th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xigduo XrDapaglifloz Propaned/Metformin | 161 | $100,424 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 80 | $66,528 |
| OzempicSemaglutide | 53 | $59,901 |
| EliquisApixaban | 41 | $46,823 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 50 | $33,771 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 28 | $32,928 |
| FarxigaDapagliflozin Propanediol | 47 | $26,660 |
| CreonLipase/Protease/Amylase | 12 | $21,964 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 28 | $18,240 |
| Diclofenac Sodium | 55 | $17,525 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $11,934 |
| LinzessLinaclotide | 17 | $11,683 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $9,980 |
| XareltoRivaroxaban | 13 | $8,480 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 25 | $8,208 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimSynjardy Xr, Trijardy Xr | $541 | $99,455108 claims |
| Novo NordiskOzempic | $475 | $59,90153 claims |
| PfizerEliquis | $233 | $46,82341 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $806 | $36,64160 claims |
| GSKTrelegy Ellipta | $120 | $33,77150 claims |
| AbbVieCreon, Linzess | $1,403 | $33,64829 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 medical providers in California.
Other medical in Los Angeles
- Jeffrey BonnaudLos Angeles$314K
- Kenny Davis TrinidadLos Angeles$99K
- Cheiny ShiauLos Angeles$86K
- Xochitl RentelnLos Angeles$38K
- Charlotte CarlsonLos Angeles$30K
- Dorna YaghoobzadehLos Angeles$18K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.